tiprankstipranks
Advertisement
Advertisement

REPL Stock Latest News

FDA issues draft guidance to help accelerated cell, gene therapies for patients
The FlyFDA issues draft guidance to help accelerated cell, gene therapies for patients
1d ago
AZN
BMY
Replimune Group trading resumes
PremiumThe Fly
Replimune Group trading resumes
2d ago
REPL
Replimune Group trading halted, volatility trading pause
PremiumThe Fly
Replimune Group trading halted, volatility trading pause
2d ago
REPL
Replimune price target raised to $6 from $2 at Wedbush
PremiumThe Fly
Replimune price target raised to $6 from $2 at Wedbush
2d ago
REPL
Replimune presents final first-in-human data for RP2 alone, with nivolumab
PremiumThe Fly
Replimune presents final first-in-human data for RP2 alone, with nivolumab
3d ago
REPL
Replimune presents 3-year overall survival data from IGNYTE trial
PremiumThe FlyReplimune presents 3-year overall survival data from IGNYTE trial
3d ago
REPL
Replimune upgraded to Neutral at JPMorgan with RP1 ‘back on the table’
Premium
The Fly
Replimune upgraded to Neutral at JPMorgan with RP1 ‘back on the table’
5d ago
REPL
Replimune upgraded to Neutral from Underweight at JPMorgan
Premium
The Fly
Replimune upgraded to Neutral from Underweight at JPMorgan
5d ago
REPL
Midday Fly By: Dell reports blowout results, Blue Origin rocket explodes
PremiumThe Fly
Midday Fly By: Dell reports blowout results, Blue Origin rocket explodes
5d ago
S
GM
Why Penny Stock Replimune (REPL) Nearly Doubled Today
PremiumMarket News
Why Penny Stock Replimune (REPL) Nearly Doubled Today
5d ago
BMY
REPL
Replimune to Resubmit Priority FDA Filing for RP1
PremiumCompany Announcements
Replimune to Resubmit Priority FDA Filing for RP1
5d ago
8K
REPL
Replimune to resubmit RP1 BLA following communications with FDA
PremiumThe Fly
Replimune to resubmit RP1 BLA following communications with FDA
5d ago
REPL
Replimune Group call volume above normal and directionally bullish
PremiumThe FlyReplimune Group call volume above normal and directionally bullish
14d ago
REPL
FDA Commissioner Marty Makary resigns
Premium
The Fly
FDA Commissioner Marty Makary resigns
22d ago
AZN
BMY
Trump confirms Kyle Diamantas to be acting head of FDA
Premium
The Fly
Trump confirms Kyle Diamantas to be acting head of FDA
22d ago
AZN
BMY
REPL Earnings this Week: How Will it Perform?
PremiumPre-Earnings
REPL Earnings this Week: How Will it Perform?
22d ago
REPL
Replimune jumps on news FDA chief behind RP1 rejection may be removed
PremiumThe Fly
Replimune jumps on news FDA chief behind RP1 rejection may be removed
26d ago
REPL
Replimune rises after Wall Street Journal editorial defending RP1
PremiumThe Fly
Replimune rises after Wall Street Journal editorial defending RP1
1M ago
REPL
Nike downgraded, Starbucks upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nike downgraded, Starbucks upgraded: Wall Street’s top analyst calls
2M ago
BBY
FIG
Video: Goldman slips after bank kicks off earnings season
PremiumThe FlyVideo: Goldman slips after bank kicks off earnings season
2M ago
GS
BKR
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
Premium
Market News
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
2M ago
IMA
VTI
Replimune downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Replimune downgraded to Neutral from Outperform at Wedbush
2M ago
REPL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >